Because the review of 48 studies, although comprehensive, looked at a wide and diverse group of people -- from those with conditions such as diabetes and kidney disease, and those with different starting and end points and who took different medications -- the conclusions drawn also highlight its limitations
BPC-157 would still require a full New Drug Application (NDA) supported by adequate human clinical trials to achieve formal FDA approval
Shepherd, P
Biana Borchenko, FNP-BC a board-certified family nurse practitioner with over 20 years of clinical experience including a decade specializing in peptide therapies, hormone optimization, and longevity medicine leads many of RWAs advanced peptide protocols
2014 follow-up study was retracted in 2025, which means the foundational evidence base has significant integrity concerns that should be weighed carefully
The nutrients in Glutathione IV drips are absorbed faster and more efficiently than supplements